Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

First Clues in Fragile Lives: Can Early Biomarkers Transform Neonatal Sepsis Detection? A Retrospective Analysis

View through CrossRef
Objectives: This retrospective study aimed to evaluate the diagnostic accuracy of C-reactive protein (CRP), procalcitonin (PCT), and presepsin for the early detection of neonatal sepsis by assessing their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in a tertiary care neonatal unit. Methodology: Conducted at the Neonatal Unit of the Pediatrics Department at Pakistan Institute of Medical Sciences (PIMS) Hospital, Islamabad, Pakistan, from May 2024 to May 2025, the study included 80 neonates (44 with confirmed sepsis, 36 without sepsis), determined by a sample size calculation based on a 36.41% sepsis prevalence, 95% confidence level, and 10% margin of error. Data were extracted from medical records, focusing on biomarker levels (CRP, PCT, presepsin) measured within 24 to 48 hours of sepsis suspicion, with analysis performed using SPSS software and Receiver Operating Characteristic (ROC) curves. Results: The cohort comprised 65% late preterm and 51.2% low birth weight neonates, with 55% diagnosed with sepsis. Mean biomarker levels were higher in septic neonates (CRP: 10.54 ± 1.88 mg/L, PCT: 0.68 ± 0.15 ng/mL, presepsin: 249.3 ± 20.5 pg/mL) compared to non-septic controls (CRP: 8.08 ± 1.11 mg/L, PCT: 0.51 ± 0.13 ng/mL, presepsin: 216.11 ± 21.01 pg/mL). Presepsin showed the highest diagnostic accuracy (AUC 0.865, sensitivity 95.5%, NPV 90.0%), followed by CRP (AUC 0.860, sensitivity 93.2%) and PCT (AUC 0.783, sensitivity 97.7%, but specificity 22.2%). Conclusion: Presepsin, CRP, and PCT are effective biomarkers for early neonatal sepsis detection, with presepsin offering the best diagnostic profile. A multi-biomarker approach could enhance clinical decision-making and reduce antibiotic overuse in resource-limited settings, necessitating further multicenter validation. Keywords: Biomarkers, C-reactive protein, Neonatal sepsis, Procalcitonin, Presepsin, Diagnostic accuracy, Pakistan.
Title: First Clues in Fragile Lives: Can Early Biomarkers Transform Neonatal Sepsis Detection? A Retrospective Analysis
Description:
Objectives: This retrospective study aimed to evaluate the diagnostic accuracy of C-reactive protein (CRP), procalcitonin (PCT), and presepsin for the early detection of neonatal sepsis by assessing their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in a tertiary care neonatal unit.
Methodology: Conducted at the Neonatal Unit of the Pediatrics Department at Pakistan Institute of Medical Sciences (PIMS) Hospital, Islamabad, Pakistan, from May 2024 to May 2025, the study included 80 neonates (44 with confirmed sepsis, 36 without sepsis), determined by a sample size calculation based on a 36.
41% sepsis prevalence, 95% confidence level, and 10% margin of error.
Data were extracted from medical records, focusing on biomarker levels (CRP, PCT, presepsin) measured within 24 to 48 hours of sepsis suspicion, with analysis performed using SPSS software and Receiver Operating Characteristic (ROC) curves.
Results: The cohort comprised 65% late preterm and 51.
2% low birth weight neonates, with 55% diagnosed with sepsis.
Mean biomarker levels were higher in septic neonates (CRP: 10.
54 ± 1.
88 mg/L, PCT: 0.
68 ± 0.
15 ng/mL, presepsin: 249.
3 ± 20.
5 pg/mL) compared to non-septic controls (CRP: 8.
08 ± 1.
11 mg/L, PCT: 0.
51 ± 0.
13 ng/mL, presepsin: 216.
11 ± 21.
01 pg/mL).
Presepsin showed the highest diagnostic accuracy (AUC 0.
865, sensitivity 95.
5%, NPV 90.
0%), followed by CRP (AUC 0.
860, sensitivity 93.
2%) and PCT (AUC 0.
783, sensitivity 97.
7%, but specificity 22.
2%).
Conclusion: Presepsin, CRP, and PCT are effective biomarkers for early neonatal sepsis detection, with presepsin offering the best diagnostic profile.
A multi-biomarker approach could enhance clinical decision-making and reduce antibiotic overuse in resource-limited settings, necessitating further multicenter validation.
Keywords: Biomarkers, C-reactive protein, Neonatal sepsis, Procalcitonin, Presepsin, Diagnostic accuracy, Pakistan.

Related Results

Neurological Complications in Sepsis
Neurological Complications in Sepsis
Background: Sepsis is a medical emergency that requires immediate assessment and management. Sepsis can affect patients at any age group which increases the number of sepsis cases....
To Determine The Association Of Serum Neopterin Levels In Sepsis
To Determine The Association Of Serum Neopterin Levels In Sepsis
Abstract ABSTRACT Background: Sepsis is a leading cause of death worldwide. Sepsis results in state of multiorgan dysfunction in the body. Early identification and appropri...
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
OBJECTIVES: Sepsis is defined as life-threatening organ dysfunction triggered by an underlying infection. A recent study noted that the overall sepsis-related mortality...
Etiology of early and late neonatal sepsis at the national institute of pediatrics from 2015 to 2019
Etiology of early and late neonatal sepsis at the national institute of pediatrics from 2015 to 2019
Neonatal sepsis is an infectious disease caused mainly by Escherichia coli bacteria in developing countries.1 The term neonatal sepsis refers to a clinical syndrome described as a ...

Back to Top